The study has the purpose to compare R-CHOP versus R-mini-CEOP in elderly patients (\>65 years) with Diffuse Large B Cell Lymphoma (DLBCL).
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
226
750 mg/mq IV, day 1
50 mg/mq IV, day 1
50 mg/mq IV, day1
S.C. di Ematologia, Spedali Civili
Brescia, Brescia, Italy
Ospedale di Vigevano
Vigevano, Pavia, Italy
Ospedale Garibaldi-Nesima
Catania, Italy
Ospedale civile Divisione di Ematologia
Event Free Survival (EFS)
Time frame: 2 years
Complete Remission (CR) rate
Time frame: 2 years
Disease Free Survival (DFS)
Time frame: 2 years
Multidimensional Evaluation Scale for the definition of "frail" and "non frail" patients
Time frame: 2 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
1,4 mg/mq (max 2 mg)IV, day 1
75 mg/mq IV, days 1-5
60 mg/mq IV/PO, days 1-5
50 mg/mq IV, day 1
5 mg/mq IV, day 1
375 mg/mq IV, day 1
300 µg tot., SC; days 7-11
Civitanova Marche (MC), Italy
Ospedale San Sebastiano
Correggio (RE), Italy
Presidio Ospedaliero Annunziata
Cosenza, Italy
Istituto Vito Fazzi
Lecce, Italy
Azienda Ospedaliera Policlinico
Modena, Italy
AO Arcispedale S.Maria Nuova Ematologia
Reggio Emilia, Italy
Ospedale civile DH oncologico
Sassuolo (MO), Italy
...and 1 more locations